| Samuel Lorenzo, MD | |
|
1360 Upper Hembree Rd, Suite 100, Roswell, GA 30076-1171 | |
| (678) 672-5100 | |
| (678) 672-5101 |
| Full Name | Samuel Lorenzo |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 1360 Upper Hembree Rd, Roswell, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316032881 | NPI | - | NPPES |
| 000408196R | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 32235 (Georgia) | Primary |
| Entity Name | Inphynet Primary Care Physicians Southeast Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770521460 PECOS PAC ID: 3779497045 Enrollment ID: O20031119000600 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
Researchers from the Cardiovascular Institute at Rhode Island, The Miriam and Newport hospitals will present 22 abstracts, both poster and oral presentations, at the upcoming American Heart Association Scientific Sessions, to be held in Dallas November 16-20, 2013. Scientific Sessions is the foremost cardiovascular research meeting in the U.S., with more than 18,000 cardiovascular experts from more than 105 countries in attendance.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.
A group led by a University of British Columbia and Vancouver Coastal Health scientist has discovered a type of spinal cord cell that could function as a stem cell, with the ability to regenerate portions of the central nervous system in people with spinal cord injuries, multiple sclerosis or amyotrophic lateral sclerosis.
Exciting data from the 26th European Society of Thoracic Surgeons meeting shows an association between innovation, and improved patient outcomes and lowered hospital costs
› Verified 6 days ago
| Entity Name | Georgia Urgent Care, - Alpharetta, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922133768 PECOS PAC ID: 4183707714 Enrollment ID: O20080206000004 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
Researchers from the Cardiovascular Institute at Rhode Island, The Miriam and Newport hospitals will present 22 abstracts, both poster and oral presentations, at the upcoming American Heart Association Scientific Sessions, to be held in Dallas November 16-20, 2013. Scientific Sessions is the foremost cardiovascular research meeting in the U.S., with more than 18,000 cardiovascular experts from more than 105 countries in attendance.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.
A group led by a University of British Columbia and Vancouver Coastal Health scientist has discovered a type of spinal cord cell that could function as a stem cell, with the ability to regenerate portions of the central nervous system in people with spinal cord injuries, multiple sclerosis or amyotrophic lateral sclerosis.
Exciting data from the 26th European Society of Thoracic Surgeons meeting shows an association between innovation, and improved patient outcomes and lowered hospital costs
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Lorenzo, MD 290 Country Club Dr, Suite 220, Stockbridge, GA 30281-9069 Ph: (678) 284-6300 | Samuel Lorenzo, MD 1360 Upper Hembree Rd, Suite 100, Roswell, GA 30076-1171 Ph: (678) 672-5100 |
News Archive
Research funded by the National Institutes of Health suggests that changes in a small region of chromosome 6 are risk factors for peanut allergy in U.S. children of European descent. The genetic risk area is located among two tightly linked genes that regulate the presentation of allergens and microbial products to the immune system. This study is the first to use a genome-wide screening approach in patients with well-defined food allergy to identify risks for peanut allergy.
Researchers from the Cardiovascular Institute at Rhode Island, The Miriam and Newport hospitals will present 22 abstracts, both poster and oral presentations, at the upcoming American Heart Association Scientific Sessions, to be held in Dallas November 16-20, 2013. Scientific Sessions is the foremost cardiovascular research meeting in the U.S., with more than 18,000 cardiovascular experts from more than 105 countries in attendance.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.
A group led by a University of British Columbia and Vancouver Coastal Health scientist has discovered a type of spinal cord cell that could function as a stem cell, with the ability to regenerate portions of the central nervous system in people with spinal cord injuries, multiple sclerosis or amyotrophic lateral sclerosis.
Exciting data from the 26th European Society of Thoracic Surgeons meeting shows an association between innovation, and improved patient outcomes and lowered hospital costs
› Verified 6 days ago
Yevheniy Lider, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 Hospital Blvd, Roswell, GA 30076 Phone: 770-751-2500 | |
Michael Lipscomb, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3000 Hospital Blvd, Roswell, GA 30076 Phone: 770-751-2567 | |
Damon C. Kimes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Upper Hembree Rd Ste B, Roswell, GA 30076 Phone: 678-736-7680 Fax: 888-537-5362 | |
Charles V Pollack Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1120 Wilde Run Ct, Roswell, GA 30075 Phone: 610-329-2986 Fax: 888-959-8345 | |
Dr. Lisa M Perez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 Bombay Ln, Roswell, GA 30076 Phone: 678-869-5158 Fax: 678-869-5159 | |
Jonathan Mills, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3000 Hospital Blvd, Roswell, GA 30076 Phone: 770-751-2567 |